UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors

Frontiers in pharmacology, 2022-08, Vol.13, p.944342-944342

2022

Volltextzugriff (PDF)

Identification of nomogram associated with durable clinical benefit gene for advanced non-small cell lung cancer with sensitivity to responsive to immunotherapy

Heliyon, 2024-04, Vol.10 (7), p.e27801-e27801, Article e27801

2024

Volltextzugriff (PDF)

Total reward satisfaction profiles and work performance: A person-centered approach

Heliyon, 2023-03, Vol.9 (3), p.e14154-e14154, Article e14154

2023

Volltextzugriff (PDF)

DNMT3A-mediated DNA methylation and transcription inhibition of FZD5 suppresses lung carcinogenesis

Heliyon, 2024-05, Vol.10 (9), p.e29733-e29733, Article e29733

2024

Volltextzugriff (PDF)

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

Frontiers in oncology, 2021-03, Vol.11, p.625578-625578

2021

Volltextzugriff (PDF)

Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance

Biological procedures online, 2023-07, Vol.25 (1), p.21-21, Article 21

2023

Volltextzugriff (PDF)

Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non‐small cell lung cancer

Thoracic cancer, 2022-02, Vol.13 (3), p.353-360

2022

Volltextzugriff (PDF)

A retrospective study of first‐line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations

Cancer medicine (Malden, MA), 2024-06, Vol.13 (12), p.e7335-n/a

2024

Volltextzugriff (PDF)

PMS2 amplification contributes brain metastasis from lung cancer

Biological procedures online, 2024-05, Vol.26 (1), p.12-12, Article 12

2024

Volltextzugriff (PDF)

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure

Thoracic cancer, 2019-04, Vol.10 (4), p.957-965

2019

Volltextzugriff (PDF)

Treatment of small cell lung cancer: recent advances

Current opinion in oncology, 2022-01, Vol.34 (1), p.83

2022

Volltextzugriff (PDF)

Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors

Lung cancer (Amsterdam, Netherlands), 2020-12, Vol.150, p.76-82

2020

Volltextzugriff (PDF)

Indoor air pollution: An important risk factor for lung cancer among Asian women without a history of smoking

Chinese Medical Journal Pulmonary and Critical Care Medicine, 2023-12, Vol.1 (4), p.198-199

2023

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitor remodels tumor microenvironment by upregulating LAG-3 in advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-03, Vol.153, p.143-149

2021

Volltextzugriff (PDF)

Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study

Cancer Immunology, Immunotherapy, 2022-07, Vol.71 (7), p.1625-1631

2022

Volltextzugriff (PDF)

Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram

Lung cancer (Amsterdam, Netherlands), 2022-08, Vol.170, p.74-84

2022

Volltextzugriff (PDF)

Erratum to “Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram” [Lung Cancer 170 (2022) 74–84]

Lung cancer (Amsterdam, Netherlands), 2022-09, Vol.171, p.121-125

2022

Volltextzugriff (PDF)

Erratum to “Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors” [Lung Cancer 150 (2020) 76–82]

Lung cancer (Amsterdam, Netherlands), 2021-03, Vol.153, p.197-197

2021

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases

Translational lung cancer research, 2020-04, Vol.9 (2), p.316-324

2020

Volltextzugriff (PDF)

IS14-4. Genetic mutations associated with lung cancer metastasis to the brain

Japanese Journal of Lung Cancer, 2019-11, Vol.59 (6), p.653-653

2019

Volltextzugriff (PDF)

Genetic mutations associated with lung cancer metastasis to the brain

Journal of global oncology, 2019-10, Vol.5 (suppl), p.41-41

2019

Volltextzugriff (PDF)

Study on the Influence of Land Use Patterns on the Comprehensive Harnessing Effects of Soil and Water Erosion

Nature environment and pollution technology, 2019-09, Vol.18 (3), p.919-930

2019

Volltextzugriff (PDF)

GIS-based risk assessment of flood disaster in the Lijiang River Basin

Scientific reports, 2023-04, Vol.13 (1), p.6160-6160, Article 6160

2023

Volltextzugriff (PDF)

Oxaliplatin based chemotherapy for advanced well-differentiated neuroendocrine tumors: A systematic review and meta-analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16240-e16240

2023

Volltextzugriff (PDF)

MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway

Toxins, 2022-11, Vol.14 (12), p.833

2022

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(36)
Tagungsberichte
(2)

Sprache

Englisch
(37)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors

Identification of nomogram associated with durable clinical benefit gene for advanced non-small cell lung cancer with sensitivity to responsive to immunotherapy

Total reward satisfaction profiles and work performance: A person-centered approach

DNMT3A-mediated DNA methylation and transcription inhibition of FZD5 suppresses lung carcinogenesis

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance

Low baseline plasma PCSK9 level is associated with good clinical outcomes of immune checkpoint inhibitors in advanced non‐small cell lung cancer

A retrospective study of first‐line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations

PMS2 amplification contributes brain metastasis from lung cancer

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure

Treatment of small cell lung cancer: recent advances

Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors

Indoor air pollution: An important risk factor for lung cancer among Asian women without a history of smoking

Epidermal growth factor receptor tyrosine kinase inhibitor remodels tumor microenvironment by upregulating LAG-3 in advanced non-small-cell lung cancer

Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study

Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram

Erratum to “Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram” [Lung Cancer 170 (2022) 74–84]

Erratum to “Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors” [Lung Cancer 150 (2020) 76–82]

Non-alcoholic fatty liver disease is associated with immune checkpoint inhibitor-based treatment response in patients with non-small cell lung cancer with liver metastases

IS14-4. Genetic mutations associated with lung cancer metastasis to the brain

Genetic mutations associated with lung cancer metastasis to the brain

Study on the Influence of Land Use Patterns on the Comprehensive Harnessing Effects of Soil and Water Erosion

GIS-based risk assessment of flood disaster in the Lijiang River Basin

Oxaliplatin based chemotherapy for advanced well-differentiated neuroendocrine tumors: A systematic review and meta-analysis

MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway

Suchergebnisse filtern